DEVELOPMENT OF PLASMACYTOID DC EXOSOMES AS NEW TYPE OF CANCER VACCINES THAT OVERCOME CDC1 DEPENDENCE AND TUMOR IMMUNOSUPPRESSION
$620,000FY2025Defense Health AgencyDOD
Henry Ford Health System, Detroit MI
Investigators
View source on USAspending →DEVELOPMENT OF PLASMACYTOID DC EXOSOMES AS NEW TYPE OF CANCER VACCINES THAT OVERCOME CDC1 DEPENDENCE AND TUMOR IMMUNOSUPPRESSION · GrantIndex